A detailed history of Price T Rowe Associates Inc transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,281,900 shares of BLCO stock, worth $14.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,281,900
Previous 781,900 63.95%
Holding current value
$14.6 Million
Previous $14.1 Million 31.62%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$14.13 - $18.15 $7.07 Million - $9.08 Million
500,000 Added 63.95%
1,281,900 $18.6 Million
Q4 2024

Feb 14, 2025

BUY
$17.79 - $21.0 $13.9 Million - $16.4 Million
781,900 New
781,900 $14.1 Million

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $3.99B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.